• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

JAMA: ECMO Centers and Mortality From Influenza A(H1N1)

tetano

Editor, Senior Moderator
JAMA. 2012;307(5):454. doi: 10.1001/jama.2012.57

Letters
JAMA. 2012;307(5):454. doi: 10.1001/jama.2012.57
ECMO Centers and Mortality From Influenza A(H1N1)

Joost D. Haeck, MD, PhD;
Dave A. Dongelmans, MD, PhD;
Marcus J. Schultz, MD, PhD



To the Editor: Dr Noah and colleagues found that the mortality rate was lower among patients with severe suspected or confirmed 2009 influenza A(H1N1) and acute respiratory distress syndrome (ARDS) who were transferred to 4 specialized centers in the United Kingdom for treatment with extracorporeal membrane oxygenation (ECMO) compared with matched critically ill patients who were not transferred.1

The ventilatory parameters in the ECMO-referred patients at transfer are shown in eTable 2 of the article. The median tidal volume was 5.2 mL/kg (interquartile range, 4.0-6.5 mL/kg) of actual body weight. However, information on the respiratory values during treatment in non?ECMO-referred patients with H1N1 and ARDS was not described. Because lower tidal volumes are associated with a lower mortality rate in ARDS patients due to reduced ventilator-associated lung injury,2 it would be valuable to also provide information on the respiratory values during treatment in non?ECMO-referred patients with H1N1 and ?


http://jama.ama-assn.org/content/307/5/454.3.extract
 
Re: JAMA: ECMO Centers and Mortality From Influenza A(H1N1)

JAMA. 2012;307(5):454-455. doi: 10.1001/jama.2012.58

Letters
JAMA. 2012;307(5):454-455. doi: 10.1001/jama.2012.58
ECMO Centers and Mortality From Influenza A(H1N1)?Reply

Giles J. Peek, FRCS (CTh), MD;
Kathryn M. Rowan, PhD



In Reply: The SwiFT (Swine Flu Triage) Study collected only a minimal set of daily critical care data for the 1756 H1N1 cases in 193 hospitals (predominantly those sufficient to calculate a Sequential Organ Failure Assessment score), given the pandemic context. More detailed additional data, however, were collected on a much smaller number of cases (n = 80) referred to 1 of the 4 ECMO centers. Therefore, as Dr Haeck and colleagues point out, information on respiratory values during treatment in non?ECMO-referred patients with H1N1 was not available.

In the absence of these definitive respiratory values during treatment for non?ECMO-referred patients, but with a view to exploring the hypothesis that Haeck et al outline, we conducted 2 sensitivity analyses limiting comparison of the ECMO-referred patients to non?ECMO-referred patients treated in critical care units either with a higher volume of ventilated patients or with a lower standardized mortality ratio?characteristics associated with better outcomes ?


http://jama.ama-assn.org/content/307/5/454.4.extract
 
Back
Top Bottom